OptimizeRx to Host Online Conversation with Leaders from HealthXL, MITX and Singularity University
2020年4月6日 - 9:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies and payers, will
continue its webinar series this week to address the
transformational nature of the coronavirus on the healthcare
industry with leaders from HealthXL, MITX and Singularity
University.
OptimizeRx is hosting this conversation to facilitate industry
collaboration that can help stop the spread of the virus. Hundreds
of members of the healthcare community have participated in the
webinar series since they began last month.
The panel will be moderated by Rebecca Love, MSN, RN and VP of
customer strategy and engagement for OptimizeRx. She will be joined
by Chandana Fitzgerald, chief medical officer at HealthXL; David
Chang, entrepreneur and angel investor, former chief operating
officer of PayPal, and current board member of Harvard Ventures,
MITX and Flybridge Capital Partners; and Shawna Butler, RN, MBA,
lead of Exponential Medicine partnerships and outreach at
Singularity University.
Topic: Learning Together—The
Transformational Nature of COVID-19 on the Healthcare
Industry.COVID-19 has become a disruptive force with a
transformational impact on many industries, especially
healthcare.
From unprecedented real-time scientific collaboration across the
globe to newly relaxed regulations, new supply chain and PPE
sourcing opportunities, and deeper reliance on digital
communication than ever before, COVID-19 is transforming the
landscape of healthcare. The discussion will address how this
disruption is providing opportunities for new technologies,
startups, and innovation to thrive, and will dive into some of the
ways healthcare is adjusting and transforming at every level.
Date: Thursday, April 9Time:
1:00 p.m. ET
The webinar is free and open to anyone in healthcare interested
in participating in a practical conversation with industry leaders.
OptimizeRx is hosting these conversations to explore the
transformational changes occurring in healthcare, and to connect
the various stakeholders in a way that drives innovation,
collaboration and education.
Register today at www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar sessions,
contact media relations at (754) 245-7070 or
malejandra@optimizerx.com.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
digital platform connecting life sciences to the point-of-care,
OptimizeRx provides a direct channel for pharma companies, payers,
medtech, and medical associations to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and Quest,
and directly via its mobile communications platform and digital
therapeutics SaaS platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both, CMATel
(949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 6 2024 まで 7 2024
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 7 2023 まで 7 2024